From: Facility-based surveillance for influenza and respiratory syncytial virus in rural Zambia
 | Influenza A | Influenza B | RSV | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Negative (n = 585) | Positive (n = 86) | Univariable PR/RR (95% CI) | Age-adjusted PR/RR (95% CI) | Negative (n = 635) | Positive (n = 36) | Univariable PR/RR (95% CI) | Age-adjusted PR/RR (95% CI) | Negative (n = 595) | Positive (n = 76) | Univariable PR/RR (95% CI) | Age-adjusted PR/RR (95% CI) | |
Pneumonia diagnosis at presentation (n,%) | 33 (6%) | 7 (8%) | 1.44 (0.66–3.16) | 1.57 (0.71–3.45) | 40 (6%) | 0 (0%) | N/A | N/A | 29 (5%) | 11 (14%) | 2.97 (1.55–5.70) | 3.21 (1.59–6.48) |
RTI diagnosis at presentation (n,%) | 412 (70%) | 65 (76%) | 1.07 (0.94–1.22) | 1.05 (0.92–3.45) | 446 (70%) | 31 (86%) | 1.23 (1.07–1.41) | 1.20 (1.03–1.39) | 417 (70%) | 60 (79%) | 1.13 (0.99–1.28) | 1.11 (0.98–1.26) |
Sepsis diagnosis at presentation (n,%) | 14 (2%) | 7 (8%) | 3.40 (1.41–8.19) | 3.50 (1.42–8.62) | 20 (3%) | 1 (3%) | 0.88 (0.12–6.39) | 0.73 (0.10–5.34) | 18 (3%) | 3 (4%) | 1.30 (0.39–4.33) | 1.06 (0.32–3.56) |
Received antibiotics (n,%) | 427 (73%) | 73 (85%) | 1.16 (1.05–1.29) | 1.12 (1.02–1.25) | 470 (74%) | 30 (83%) | 1.13 (0.97–1.31) | 1.07 (0.92–1.25) | 431 (72%) | 69 (91%) | 1.25 (1.15–1.37) | 1.20 (1.10–1.31) |
Severe clinical illness (n,%)a | 133 (32%) | 32 (38%) | 1.18 (0.95–1.46) | 1.18 (0.97–1.43) | 160 (34%) | 5 (14%) | 0.42 (0.21–0.82) | 0.56 (0.29–1.11) | 132 (29%) | 33 (65%) | 1.82 (1.53–2.18) | 1.78 (1.51–2.11) |
Inpatient admission (n,%)b | 85 (17%) | 23 (27%) | 1.47 (1.13–1.91) | 1.42 (1.12–1.79) | 106 (19%) | 2 (6%) | 0.34 (0.13–0.86) | 0.58 (0.23–1.50) | 91 (17%) | 17 (27%) | 1.45 (1.09–1.94) | 1.53 (1.20–1.95) |
Oxygen saturation ≤ 92% (n,%)c | 68 (15%) | 13 (16%) | 1.05 (0.61–1.80) | 1.01 (0.58–1.75) | 77 (15%) | 4 (11%) | 0.75 (0.29–1.92) | 0.71 (0.27–1.83) | 63 (13%) | 18 (38%) | 2.91 (1.89–4.48) | 2.62 (1.68–4.06) |
Died (n,%)d | 10 (2%) | 0 (0%) | N/A | N/A | 10 (2%) | 0 (0%) | N/A | N/A | 10 (2%) | 0 (0%) | N/A | N/A |